Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study
Sign Up to like & getrecommendations! Published in 2021 at "Computers in Biology and Medicine"
DOI: 10.1016/j.compbiomed.2021.105155
Abstract: Angiotensin-converting enzyme 2 (ACE2) is the first target of SARS-CoV-2 and a key functional host receptor through which this virus hooks into and infects human cells. The necessity to block this receptor is one of… read more here.
Keywords: study; sars cov; cov entry; angiotensin converting ... See more keywords
Proteases and variants: context matters for SARS-CoV-2 entry assays
Sign Up to like & getrecommendations! Published in 2021 at "Current Opinion in Virology"
DOI: 10.1016/j.coviro.2021.07.004
Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), like other coronaviruses, relies on a flexible array of entry mechanisms, driven by the spike (S) protein. Entry is dependent on proteolytic priming, activation, and receptor binding; all… read more here.
Keywords: proteases variants; entry assays; variants context; cov entry ... See more keywords
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
Sign Up to like & getrecommendations! Published in 2022 at "Slas Discovery"
DOI: 10.1016/j.slasd.2021.12.005
Abstract: Effective small molecule therapies to combat the SARS-CoV-2 infection are still lacking as the COVID-19 pandemic continues globally. High throughput screening assays are needed for lead discovery and optimization of small molecule SARS-CoV-2 inhibitors. In… read more here.
Keywords: sars cov; entry; cov entry; throughput screening ... See more keywords
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.0c00502
Abstract: Recently, a novel coronavirus initially designated 2019-nCoV but now termed SARS-CoV-2 has emerged and raised global concerns due to its virulence. SARS-CoV-2 is the etiological agent of “coronavirus disease 2019”, abbreviated to COVID-19, which despite… read more here.
Keywords: current future; entry current; inhibitors sars; cov entry ... See more keywords
Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products
Sign Up to like & getrecommendations! Published in 2021 at "Signal Transduction and Targeted Therapy"
DOI: 10.1038/s41392-021-00531-5
Abstract: Dear Editor, Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health issue. The spike (S) protein mutation D614G became dominant in SARS-CoV-2 during a global pandemic,… read more here.
Keywords: supplementary fig; cov entry; entry; fusion ... See more keywords
HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
Sign Up to like & getrecommendations! Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.01150-22
Abstract: Here, we provide the first experimental evidence for the coexistence of SARS-CoV-2 infection with HCV, and the interplay between them. The study revealed a complex relationship of enhancement between the two viruses, where HCV infection… read more here.
Keywords: infection; cov entry; hcv; hcv sars ... See more keywords
Nasal expression of SARS-CoV-2 entry receptors in newborns
Sign Up to like & getrecommendations! Published in 2021 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2020-321334
Abstract: Background SARS-CoV-2 infection is typically mild in children. Lower expression of SARS-CoV-2 entry receptors in the nasal epithelia have been described in children compared with adults. However, data from newborns are lacking. We compared nasal… read more here.
Keywords: expression; entry receptors; sars cov; cov entry ... See more keywords
Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of molecular endocrinology"
DOI: 10.1530/jme-21-0282
Abstract: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Following initial infection of airway epithelia, SARS-CoV-2 invades a wide range of cells in multiple organs, including pancreatic islet cells.… read more here.
Keywords: entry; viral entry; cov entry; islet ... See more keywords
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1080897
Abstract: Background Drug repurposing is a fast and effective way to develop drugs for an emerging disease such as COVID-19. The main challenges of effective drug repurposing are the discoveries of the right therapeutic targets and… read more here.
Keywords: inflammation; hamster model; methotrexate; cov entry ... See more keywords
Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2020.619453
Abstract: SARS-CoV-2 enters into human airway epithelial cells via membrane fusion or endocytosis, and this process is dependent on ACE2, TMPRSS2, and cathepsin L. In this study, we examined the expression profiles of the three SARS-CoV-2… read more here.
Keywords: epithelial cells; airway epithelial; expression; human airway ... See more keywords
Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23179659
Abstract: COVID-19, caused by the highly transmissible severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly spread and become a pandemic since its outbreak in 2019. We have previously discovered that aloperine is a new privileged scaffold… read more here.
Keywords: quinolizidines novel; entry; entry inhibitors; cov entry ... See more keywords